Page last updated: 2024-10-26

9-(2-hydroxy-3-nonyl)adenine and Leukemia, Lymphocytic

9-(2-hydroxy-3-nonyl)adenine has been researched along with Leukemia, Lymphocytic in 3 studies

9-(2-hydroxy-3-nonyl)adenine: specific inhibitor of adenosine deaminase

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19903 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kefford, RF1
Fox, RM1
McCairns, E1
Fahey, D1
Muscat, GE1
Rowe, PB1
Deibel, MR1
Coleman, MS1
Hutton, JJ1
Plunkett, W1

Trials

1 trial available for 9-(2-hydroxy-3-nonyl)adenine and Leukemia, Lymphocytic

ArticleYear
Inhibition of adenosine deaminase to increase the antitumor activity of adenine nucleoside analogues.
    Annals of the New York Academy of Sciences, 1985, Volume: 451

    Topics: Adenine; Adenosine Deaminase Inhibitors; Adult; Animals; Carcinoma, Ehrlich Tumor; Clinical Trials a

1985

Other Studies

2 other studies available for 9-(2-hydroxy-3-nonyl)adenine and Leukemia, Lymphocytic

ArticleYear
Terminal incorporation of 2'-deoxyadenosine into polyadenylate segments of polyadenylated RNA in G1-phase-arrested human T-lymphoblasts.
    Cancer research, 1983, Volume: 43, Issue:5

    Topics: Adenine; Cell Line; Chromatography, High Pressure Liquid; Cytoplasm; Deoxyadenosines; Flow Cytometry

1983
Effect of adenosine deaminase inhibitors on the apparent rate of phosphorylation of deoxyadenosine.
    Biochemical medicine, 1981, Volume: 25, Issue:3

    Topics: Adenine; Adenosine Deaminase Inhibitors; Cell Line; Coformycin; Deoxyadenosines; Enzyme Inhibitors;

1981